P 1 | P 2 | P 3 | P 4 | P 5 | P 6 | P 7 | P 8 | P 9 | P 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Matched study group | yes | yes | yes | yes | yes | yes | yes | yes | no | no |
Age | 50 | 46 | 45 | 60 | 46 | 28 | 27 | 51 | 38 | 14 |
Gender | f | m | m | m | m | f | f | m | m | m |
First clinical examination | ||||||||||
HIV parameters | ||||||||||
HIV status | + | + | + | + | - | - | - | - | - | - |
HIV stage | I | I | I | III | - | - | - | - | - | - |
HAART drugs | ZDV/3TC/EFZ | ZDV/3TC/EFZ | ZDV/3TC/EFZ | ZDV/3TC/EFZ | - | - | - | - | - | - |
HAART treatment since (years) | <1 | 3 | 3 | 4 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
NCC symptoms/signs | - | - | - | headaches | - | severe headaches | - | - | epi | epi, enca |
CT diagnosis | ||||||||||
Calcified cysts | + | - | + | + | o | o | o | o | + | - |
Viable cysts | - | - | - | - | o | o | o | o | - | + |
Other NCC relevant findings | - | - | - | - | o | o | o | o | - | hydrocephalus |
Laboratory diagnosis | ||||||||||
CD4+ counts | 554 | 433 | 276 | 170 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
CC- Ab | + | + | + | + | + | + | + | + | + | + |
CC-Ag | - | - | - | + | - | - | - | - | - | + |
Taeniosis-Ab | + | - | - | - | - | - | + | + | + | + |
Second clinical examination | ||||||||||
NCC symptoms/signs | x | x | - | - | - | severe headaches | - | x | d | epi, enca |
CT diagnosis | x | |||||||||
Calcified cysts | x | x | + | + | + | - | + | x | d | + |
Viable cysts | x | x | - | - | - | - | - | x | d | + |
Other NCC relevant findings | x | x | - | - | - | hydrocephalusb | - | x | d | hydrocephalus |
Laboratory findings | ||||||||||
CD4+ counts | 521 | 400 | 368 | 184 | n.a. | n.a. | n.a. | n.a. | d | n.a. |
CC-Ab | + | + | - | - | + | x | x | x | d | x |
CC-Ag | - | - | - | + | - | x | x | x | d | x |
Taeniosis-Ab | + | - | - | - | - | x | x | x | d | x |
Taeniosis-copro-Ag | - | - | - | - | - | - | - | x | d | x |